Please try another search
NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Soo-Hyoung Kang | 68 | - | Director |
Hyunseok Kang | - | 2022 | Member of Scientific Advisory Board |
Benny J. Chen | - | 2023 | Member of Scientific Advisory Board |
Rafi Ahmed | - | 2019 | Member of Scientific Advisory Board |
Jin-Hyoung Kang | - | 2021 | Director |
Luke Yun Suk Oh | - | 2024 | President ,CEO & Chairman |
Richard Kim | - | 2022 | Member of Scientific Advisory Board |
Keith Watson | - | 2022 | Member of Scientific Advisory Board |
Sung-June Hong | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review